Latest tumor Stories
Peer-Reviewed Case Study from Fox Chase Cancer Center Demonstrates Value of Company's Unique Approach to Precision Medicine to Uncover Critical Treatment Insights IRVING, Texas, Aug.
Although mutations in a gene dubbed "the guardian of the genome" are widely recognized as being associated with more aggressive forms of cancer, researchers at the University of California, San Diego School of Medicine have found evidence suggesting that the deleterious health effects of the mutated gene may in large part be due to other genetic abnormalities, at least in squamous cell head and neck cancers.
Brian Olson Discusses Diagnosis, Importance of Patient Resources and Support Chicago, IL (PRWEB) July 25, 2014 There are 700,000 people in the U.S.
Harvard Neuro-Oncologist presents latest brain tumor research and treatment options at American Brain Tumor Association’s annual conference. Chicago, IL (PRWEB)
Transparency Market Research published a new report "Circulating Tumor Cells (CTCs) Prognostic Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014
Pioneer in uniting imaging technology with radiotherapy to explore potential of MRI to refine tumor targeting MANCHESTER, England, July 22, 2014 /PRNewswire/ -- Elekta (NSE:EKTAb)
Researchers at the Western Connecticut Health Network Biomedical Research Institute use a multidisciplinary integrated approach to discover possible predictive biomarkers of tumor behavior for
HER3-positive circulating tumor cells home in on omentum; new target to thwart metastasis
Eighty Percent of Patients Treated with G-202 had No Tumor Growth at Two Months SAN ANTONIO, July 15, 2014 /PRNewswire/ -- GenSpera, Inc.